New study reveals breast cancer drug combination has impact on other cancers
4 Mar 2024
- Drug commonly used to treat HER2-positive breast cancer sees tumour shrinkage in several other cancer types.
- Cancer treatment combination may have more uses than previously thought.
UCC Research
Aistriú Taighde
Contact us
Office of Vice President for Research & Innovation, 4th Floor, Block E, Food Science Building University College Cork, T12 K8AF